Montemiglio Linda Celeste, Parisi Giacomo, Scaglione Antonella, Sciara Giuliano, Savino Carmelinda, Vallone Beatrice
Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, P.le A. Moro 5, 00185 Rome, Italy; Department of Biochemical Sciences, "Sapienza" University of Rome, P.le A. Moro 5, 00185 Rome, Italy.
CNR Institute of Molecular Biology and Pathology, P.le A. Moro 5, 00185 Rome, Italy.
Biochim Biophys Acta. 2016 Mar;1860(3):465-75. doi: 10.1016/j.bbagen.2015.10.009. Epub 2015 Oct 22.
OleP is a cyt P450 from Streptomyces antibioticus carrying out epoxigenation of the antibiotic oleandomycin during its biosynthesis. The timing of its reaction has not been fully clarified, doubts remain regarding its substrate and catalytic mechanism.
The crystal structure of OleP in complex with clotrimazole, an inhibitor of P450s used in therapy, was solved and the complex formation dynamics was characterized by equilibrium and kinetic binding studies and compared to ketoconazole, another azole differing for the N1-substituent.
Clotrimazole coordinates the heme and occupies the active site. Most of the residues interacting with clotrimazole are conserved and involved in substrate binding in MycG, the P450 epoxigenase with the highest homology with OleP. Kinetic characterization of inhibitor binding revealed OleP to follow a simple bimolecular reaction, without detectable intermediates.
Clotrimazole-bound OleP adopts an open form, held by a π-π stacking chain that fastens helices F and G and the FG loop. Affinity is affected by the interactions of the N1 substituent within the active site, given the one order of magnitude difference of the off-rate constants between clotrimazole and ketoconazole. Based on structural similarities with MycG, we propose a binding mode for both oleandomycin intermediates, that are the candidate substrates of OleP.
Among P450 epoxigenases OleP is the only one that introduces an epoxide on a non-activated C–C bond. The data here presented are necessary to understand the rare chemistry carried out by OleP, to engineer it and to design more selective and potent P450-targeted drugs.
OleP是来自抗生链霉菌的一种细胞色素P450,在抗生素竹桃霉素的生物合成过程中对其进行环氧化反应。其反应时机尚未完全阐明,关于其底物和催化机制仍存在疑问。
解析了OleP与克霉唑(一种治疗中使用的P450抑制剂)复合物的晶体结构,并通过平衡和动力学结合研究对复合物形成动力学进行了表征,并与酮康唑(另一种N1取代基不同的唑类)进行了比较。
克霉唑与血红素配位并占据活性位点。与克霉唑相互作用的大多数残基是保守的,并且参与了MycG中的底物结合,MycG是与OleP同源性最高的P450环氧化酶。抑制剂结合的动力学表征表明OleP遵循简单的双分子反应,没有可检测到的中间体。
与克霉唑结合的OleP采用开放形式,由一个π-π堆积链固定,该链固定螺旋F和G以及FG环。鉴于克霉唑和酮康唑之间的解离速率常数相差一个数量级,亲和力受活性位点内N1取代基相互作用的影响。基于与MycG的结构相似性,我们提出了两种竹桃霉素中间体(即OleP的候选底物)的结合模式。
在P450环氧化酶中,OleP是唯一一种在未活化的C-C键上引入环氧化物的酶。此处提供的数据对于理解OleP所进行的罕见化学反应、对其进行工程改造以及设计更具选择性和效力的P450靶向药物是必要的。